INDOLENT SYSTEMIC MASTOCYTOSIS
Clinical trials for INDOLENT SYSTEMIC MASTOCYTOSIS explained in plain language.
Never miss a new study
Get alerted when new INDOLENT SYSTEMIC MASTOCYTOSIS trials appear
Sign up with your email to follow new studies for INDOLENT SYSTEMIC MASTOCYTOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug study aims to tame debilitating mast cell disease symptoms
Disease control Recruiting nowThis study is observing how well the drug avapritinib works for people with indolent systemic mastocytosis (ISM) whose symptoms aren't controlled by standard treatments. It will follow about 80 patients in Germany for up to two years as they take the drug as part of their normal …
Matched conditions: INDOLENT SYSTEMIC MASTOCYTOSIS
Sponsor: Blueprint Medicines Corporation • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New drug trial offers hope for debilitating mast cell disease symptoms
Disease control Recruiting nowThis study is testing whether an investigational drug called BLU-263 can better control symptoms in people with indolent systemic mastocytosis whose current treatments aren't working well enough. Researchers will compare BLU-263 plus standard symptom treatments against placebo pl…
Matched conditions: INDOLENT SYSTEMIC MASTOCYTOSIS
Phase: PHASE2, PHASE3 • Sponsor: Blueprint Medicines Corporation • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC